Swedish medtech company IRRAS has raised SKr217m (US$22.3m) in a fully underwritten rights issue to help commercialise its products. Disappointingly, only 56.8% of the offered shares, were subscribed for by exercise of subscription rights. The remainder were picked up by the leads. Carnegie Investment Bank was global coordinator and joint bookrunner together with Pareto Securities….
©2022 All rights reserved LaingBuisson 
 in a fully underwritten rights issue to help commercialise its products.){kind=link}